Literature DB >> 12871452

Biphasic pro-thrombotic and inflammatory responses after coronary artery bypass surgery.

N Li1, R Astudillo, T Ivert, P Hjemdahl.   

Abstract

Early graft failure after coronary artery bypass grafting (CABG) is related to thrombosis and inflammation in the grafted vessel(s). The time courses of, and relationships between, pro-thrombotic and inflammatory responses to CABG surgery have, however, not been well defined. Fifteen patients undergoing CABG were examined before, and 1 h, 1 day, 7 days, and 3 months after surgery. Cellular markers of platelet and leukocyte activation were monitored by whole blood flow cytometry, and plasma markers of pro-thrombotic and inflammatory responses were analyzed by immunoassays. CABG immediately increased circulating P-selectin-positive platelets, leukocyte CD11b expression, and platelet-leukocyte aggregates (PLAs). Thrombin generation (F1 + 2 levels) and cytokine release [tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-8, and IL-10], soluble P-selectin, and soluble E-selectin also increased immediately. These alterations persisted during the first week after surgery, with re-bound increases of circulating activated platelets and PLAs, TNF-alpha, and F1 + 2 on day 7. Platelet and PLA responsiveness to in vitro stimulation was suppressed immediately after CABG, but markedly enhanced 1 week after surgery. After 3 months, plasma soluble P-selectin, F1 + 2, and IL-10, and monocyte CD11b expression were still slightly elevated compared with baseline. In conclusion, CABG induces marked pro-thrombotic and inflammatory responses, which persist for at least 1 week. Platelet activation, platelet reactivity, PLA formation, thrombin generation, and TNF-alpha release show a second peak 1 week after surgery. These findings suggest that intensified and prolonged antithrombotic/inflammatory treatment should be considered after CABG surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871452     DOI: 10.1046/j.1538-7836.2003.00109.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  6 in total

1.  Activation of coagulation and fibrinolysis during coronary artery bypass grafting: a comparison between on-pump and off-pump techniques.

Authors:  Shreosee Roy; Kaushik Saha; Krishnendu Mukherjee; Santanu Dutta; Debasis Mukhopadhyay; Indranil Das; Gargi Raychaudhuri
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

2.  Alterations in biomarkers of endothelial function following on-pump coronary artery revascularization.

Authors:  Ioannis Panagiotopoulos; George Palatianos; Argyris Michalopoulos; Antonios Chatzigeorgiou; Sotirios Prapas; Elli F Kamper
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  First-in-Man Study With Inclacumab, a Human Monoclonal Antibody Against P-selectin.

Authors:  Christophe Schmitt; Markus Abt; Cornelia Ciorciaro; Dorothee Kling; Candice Jamois; Eginhard Schick; Corinne Solier; Renée Benghozi; Jacques Gaudreault
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

4.  Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study.

Authors:  Nathalie Layios; Céline Delierneux; Alexandre Hego; Justine Huart; Christian Gosset; Christelle Lecut; Nathalie Maes; Pierre Geurts; Arnaud Joly; Patrizio Lancellotti; Adelin Albert; Pierre Damas; André Gothot; Cécile Oury
Journal:  Intensive Care Med Exp       Date:  2017-07-12

Review 5.  Platelet-Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases.

Authors:  Kinga Pluta; Kinga Porębska; Tomasz Urbanowicz; Aleksandra Gąsecka; Anna Olasińska-Wiśniewska; Radosław Targoński; Aleksandra Krasińska; Krzysztof J Filipiak; Marek Jemielity; Zbigniew Krasiński
Journal:  Biology (Basel)       Date:  2022-01-30

6.  Tubular TPU/SF nanofibers covered with chitosan-based hydrogels as small-diameter vascular grafts with enhanced mechanical properties.

Authors:  Sasan Maleki; Amir Shamloo; Farnoosh Kalantarnia
Journal:  Sci Rep       Date:  2022-04-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.